Index
FNA (fine-needle aspiration)
(Continued)
transbronchial, 306
transmucosal, 374
transrectal, 294
ultrasound guidance
see
US-FNA
(ultrasound FNA)
vulva, 273
FNCLCC (Fédération Nationale des Centers de
Lutte Contré le Cancer), 472
FNR (false-negative rate), 61
focal lymphocytic 'nonspecific' thyroiditis, 639
focal nodular hyperplasia, liver, 882,
883
in children, 924
Focal Point System, automated quality
assurance mechanisms, 61
follicular cervicitis, 104-105,
106
follicular cysts, ovaries, 295
follicular lymphoma, 30
interphase FISH (I-FISH),
41
follicular thyroid carcinoma, 39,
69
foreign-body vaginitis, 98
form alin, and effusions
avoidance o f in collections, 516
tinted, in cell block technique, 518
FOXP1
(Forkhead box-P1), transcription
factor, 31
fumarate hydratase (FH), 819
fungal infections, 122-123
effusions, 544-546
meningitis, 442
respiratory tract, 321-327
skin, 502
vulva, 274
fungi
Aureobasidium pullulans
,
102,
103
Candida albicans
,
122
Torulopsis glabrata
,
122
G
G.
vaginalis
infections, 96, 97
galactocele, aspirate of,
735
ganglioneuroblastoma, 796-798, 856-857
ganglioneuroma, 796-798, 856-857
gap junctions, 9
gardiasis, effusions, 543
gastric cancer, gene expression signatures,
12
gastric tumors, in children, 924
gastritis
acute, 386
atrophic, 388
Helicobacter
-associated, 30, 386-387
gastroesophageal reflux disease
(GERD), 376, 380
gastrointestinal tract, 373-403
anus
see
anus
atypia, gastrointestinal epithelial
reparative, 375-376
biliary tract, 401-403
duodenum, 395-397
effusions, carcinoma, 565
esophagus, 376-385
exfoliative and aspiration cytology, 373
large intestine, 398-400
pediatric disorders, 924
specimen collection and preparation,
374-375
stomach, 385-395
upper abdominal malignancies, 291
G-band staining, chromosomes
karyotyping, 25,
26, 27
nucleus contents, 4
GCB (germinal center B-cell like gene), diffuse
large B-cell lymphoma, 34
GCLs
see
glandular cell lesions, cervix
gel electrophoretic studies, ectocervical
epithelium, 136
Gelman filters, CSF cytology, 439
gene chip technology, HPV virus, 1084-1085
gene expression signatures, 11-12
gene rearrangement studies,
lymphoproliferative disorders, 963
genes
cancer cells, biological phenotype, 11
cancer-related, 13-14
mutations, 14, 23
genetics
see also
chromosomes; DNA
(deoxyribonucleic acid); genes;
genetic code, 4
hereditary cancer syndromes, 13
kidney cancer, 818-837
tw o-hit hypothesis, hereditary cancer, 13
genital tract
epithelial cells, 91
female
see
female genital tract
lymphomas, 267
male, tumors of, 935
genococcus vaginitis, 98
GERD (gastroesophageal reflux disease), 376,
380
germ cell tumors
immunocytochemistry, 1065
ovarian, 297
in children, 933
retroperitoneum, 863-864
gestational trophoblastic disease (GTD),
267-268
GFAP (glial fibrillary acid protein), 447
ghost cells, orbital infections, 461
giant cell formation, viral infections, 106
giant cell macrophages, lung, 316
giant cell tumors
o f bone, in children, 941
bone lesions, 499
lung cancer, 333,
344
o f tendon sheath, 477-478
giardiasis
duodenum, 395, 396, 397
effusions, 543
Giemsa staining, 25
basal cell carcinoma, 503
fibrohistiocytic tumors, 498
mediastinum, 778, 790
modified May-Grunwald-Giemsa,
technique
see
May-Grunwald Giemsa
(modified) stain
and skin lesions, 502
soft tissue tumors, 475
vitrectomy (intraocular washing),
456-457
giliomas, central nervous system, 447-448
GISTs (GI stromal tumors), 392, 393
glandular cell abnormalities, epithelial
see also
glandular cell lesions, cervix
AGUS (atypical glandular cells of
undetermined significance), 85, 95
atypical, 85-86, 87
glandular cell abnormalities,
epithelial
(Continued)
background, 85
diagnostic difficulties, 86-87
endocervical cells, atypical, 86
management, 87
NILM categorization, 82
reporting, in TBS, 2001, 85
glandular cell lesions, cervix, 213-242
atypical glandular cells, 213, 224-230
high-grade squamous dysplasias as,
231-233, 232, 233
management, 241-242
atypical repair, 233
benign/non-glandular neoplastic
processes, 230-237
"birth cohort" effect, 213
characteristics, 177-178
diagnostic accuracy, 237-240
direct sampling of endometrium,
235-236, 238,
239
endocervical adenocarcinoma, 220-224
endocervical adenocarcinoma in situ,
218-220
endocervical canal, normal histology/
cytology, 213-214,
215
,
216
endocervical polyps, 236-237,
240
"honeycombed" appearance, 214,
215
and human papillomavirus, 214-215
co-factors, 215, 217-218
IUD effect, 234,
236
management, 241-242
"picket-fence" appearance, 214
tubal metaplasia, 214,
216
,
230-231
glaucoma, phacolytic, 464
glial fibrillary acid protein (GFAP), 447
glomus tumors, 479-480
GLUT-1, marker, 1053
Goblet cells
conjunctiva, 459
Golgi apparatus, 7
hyperplasia, 306,
307
norm al epithelium, 308
Golgi apparatus, 7-8
G-proteins, cell membrane, 9
grading o f tumors
see also
tum or markers
breast disorders, 758-760
cervical intraepithelial neoplasia (CIN)
see CIN grade 1,2 and 3 lesions
renal cell carcinoma, 823
clear cell renal carcinoma,
conventional, 822
soft tissue tumors, 472
squamous intraepithelial lesions
see
HSIL
(high-grade squamous intraepithelial
lesions); LSIL (low-grade squamous
intraepithelial lesions)
urinary tract, 418, 419-421, 434
gram-positive and negative bacteria, 61, 321
and skin infections, 502
granular cell tumor, breast, 732,
735
granuloma inguinale, 99
granulomas
breast disorders, 718
liver disorders, 877-878
granulomatous cervicitis, 99-100
granulomatous lymphadenitis, 680-683
mediastinum, 777-778
1103
previous page 1086 ComprehensiveCytopathology 1104p 2008 read online next page 1088 ComprehensiveCytopathology 1104p 2008 read online Home Toggle text on/off